Skip links

Creative Solutions to Complex Challenges

Camargo is now a division of Premier Research, a leading clinical research and development company. This acquisition will enhance and strengthen Premier Research’s dedication to supporting innovators working to transform life-changing ideas and breakthrough science into new medical treatments.

About Premier About Camargo

Experts in the Path to Approval

We have experience in accelerated approval pathways, rare and specialty patient populations, and innovative science including orphan drugs, the 505(b)(2) pathway, oncology, neurology, pediatrics, combination products, and digital therapeutics.

Oncology Expertise 505(b)(2) Expertise

Solutions

Across the development lifecycle, our integrated solutions and cross-functional team provide customized support for your program—from the earliest stages of strategy and planning through FDA approval to commercialization.

Strategy

Drive regulatory and commercial success for your drug, device, or combination product through a comprehensive strategic approach and development plan.

Strategy

Regulatory

Ensure flawless interactions with regulatory agencies—from initial strategy, to submissions and meetings—informed by frequent interactions and up-to-date information.

Regulatory

CMC Services

Avoid unnecessary delays and costs by integrating CMC components early in the development program, including strategic insights and management on vendors, processes, and quality controls.

CMC Services

Nonclinical

Reduce short- and long-term costs through a robust nonclinical program with support in methodology and strategy, study design, development, and accountability for program execution.

Non-Clinical

Clinical & PK

Move your product efficiently and successfully through the clinic using a customized clinical design solution with an eye towards differentiated product labeling.

Clinical & PK

Latest Insights

Blog & Resources